Genetic disorders of nuclear receptors.
Achermann, John C
J Clin Invest
American Society for Clinical Investigation
MetadataShow full item record
Achermann, J. C., Schwabe, J., Fairall, L., & Chatterjee, K. (2017). Genetic disorders of nuclear receptors.. J Clin Invest, 127 (4), 1181-1192. https://doi.org/10.1172/JCI88892
Following the first isolation of nuclear receptor (NR) genes, genetic disorders caused by NR gene mutations were initially discovered by a candidate gene approach based on their known roles in endocrine pathways and physiologic processes. Subsequently, the identification of disorders has been informed by phenotypes associated with gene disruption in animal models or by genetic linkage studies. More recently, whole exome sequencing has associated pathogenic genetic variants with unexpected, often multisystem, human phenotypes. To date, defects in 20 of 48 human NR genes have been associated with human disorders, with different mutations mediating phenotypes of varying severity or several distinct conditions being associated with different changes in the same gene. Studies of individuals with deleterious genetic variants can elucidate novel roles of human NRs, validating them as targets for drug development or providing new insights into structure-function relationships. Importantly, human genetic discoveries enable definitive disease diagnosis and can provide opportunities to therapeutically manage affected individuals. Here we review germline changes in human NR genes associated with "monogenic" conditions, including a discussion of the structural basis of mutations that cause distinctive changes in NR function and the molecular mechanisms mediating pathogenesis.
Genetic Diseases, Inborn, Humans, Mutation, Receptors, Cytoplasmic and Nuclear
Medical Research Council (MC_UU_12012/5)
Wellcome Trust (095564/Z/11/Z)
External DOI: https://doi.org/10.1172/JCI88892
This record's URL: https://www.repository.cam.ac.uk/handle/1810/282962
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org